SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Article References

HAMPTON, Lee M; ZELL, Elizabeth R; SCHRAG, Stephanie  and  COHEN, Adam L. Sentinel versus population-based surveillance of pneumococcal conjugate vaccine effectiveness. Bull World Health Organ [online]. 2012, vol.90, n.8, pp.568-577. ISSN 0042-9686.

    1. O'Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 2009;374:893–902. doi:10.1016/S0140-6736(09)61204-6 PMID:19748398 [ Links ]

    2. Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003;348:1737–46. doi:10.1056/NEJMoa022823 PMID:12724479 [ Links ]

    3. Pilishvili T, Lexau C, Farley MM, Hadler J, Harrison LH, Bennett NM et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 2010;201:32–41. doi:10.1086/648593 PMID:19947881 [ Links ]

    4. Cutts FT, Zaman SM, Enwere G, Jaffar S, Levine OS, Okoko JB et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in the Gambia: randomised, double-blind, placebo controlled trial. Lancet 2005;365:1139–46. doi:10.1016/S0140-6736(05)71876-6 PMID:15794968 [ Links ]

    5. Klugman KP, Madhi SA, Huebner RE, Kohberger R, Mbelle N, Pierce N et al. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med 2003;349:1341–8. doi:10.1056/NEJMoa035060 PMID:14523142 [ Links ]

    6. World Health Organization. Pneumococcal conjugate vaccine for childhood immunization – WHO position paper. Wkly Epidemiol Rec 2007;82:93–104. PMID:17380597 [ Links ]

    7. Knoll MD, Moisi JC, Muhib FB, Wonodi CB, Lee EH, Grant L et al. Standardizing surveillance of pneumococcal disease. Clin Infect Dis 2009;48:S37–48. doi:10.1086/596480 PMID:19191618 [ Links ]

    8. Lynfield R, Van Beneden CA. Public health surveillance for infectious diseases. In: Lee LM, Teutsch SM, Thacker SB, St Louis ME, editors. Principles and practice of public health surveillance, 3rd edn. Oxford: Oxford University Press; 2010. pp. 236–54. [ Links ]

    9. Global framework for immunization monitoring and surveillance. Geneva: World Health Organization; 2007. [ Links ]

    10. Schrag SJ, Zell ER, Schuchat A, Whitney CG. Sentinel surveillance: a reliable way to track antibiotic resistance in communities? Emerg Infect Dis 2002;8:496–502. PMID:11996685 [ Links ]

    11. Montana LS, Mishra V, Hong R. Comparison of HIV prevalence estimates from antenatal care surveillance and population surveillance surveys in sub-Saharan Africa. Sex Transm Infect 2008;84:i78–84. doi:10.1136/sti.2008.030106 PMID:18647871 [ Links ]

    12. Schuchat A, Hilger T, Zell ER, Farley MM, Reingold A, Harrison L et al. Active Bacterial Core surveillance of the emerging infections program network. Emerg Infect Dis 2001;7:92–9. doi:10.3201/eid0701.010114 PMID:11266299 [ Links ]

    13. US census populations with bridged race categories [Internet]. Atlanta: Centers for Disease Control and Prevention; 2011. Available from: [accessed 28 March 2012] [ Links ]

    14. Levine OS, Cherian T, Hajjeh R, Knoll MD. Progress and future challenges in coordinated surveillance and detection of pneumococcal and Hib disease in developing countries. Clin Infect Dis 2009;48:S33–6. doi:10.1086/596479 PMID:19191617 [ Links ]

    15. Kisakye A, Makumbi I, Nansera D, Lewis R, Braka F, Wobudeya E et al. Surveillance for Streptococcus pneumoniae meningitis in children aged <5 years: implications for immunization in Uganda. Clin Infect Dis 2009;48:S153–61. doi:10.1086/596495 PMID:19191611 [ Links ]

    16. Saha SK, Naheed A, El Arifeen S, Islam M, Al-Emran H, Amin R et al. Surveillance for invasive Streptococcus pneumoniae disease among hospitalized children in Bangladesh: antimicrobial susceptibility and serotype distribution. Clin Infect Dis 2009;48:S75–81. doi:10.1086/596544 PMID:19191622 [ Links ]

    17. Batuwanthudawe R, Karunarathne K, Dassanayake M, de Silva S, Lalitha MK, Thomas K et al. Surveillance of invasive pneumococcal disease in Colombo, Sri Lanka. Clin Infect Dis 2009;48:S136–40. doi:10.1086/596492 PMID:19191609 [ Links ]

    18. Williams EJ, Thorson S, Maskey M, Mahat S, Hamaluba M, Dongol S et al. Hospital-based surveillance of invasive pneumococcal disease among young children in urban Nepal. Clin Infect Dis 2009;48:S114–22. doi:10.1086/596488 PMID:19191606 [ Links ]

    19. Shah AS, Knoll MD, Sharma PR, Moisi JC, Kulkarni P, Lalitha MK et al. Invasive pneumococcal disease in Kanti Children's Hospital, Nepal, as observed by the South Asian Pneumococcal Alliance network. Clin Infect Dis 2009;48:S123–8. doi:10.1086/596490 PMID:19191607 [ Links ]

    20. Falade AG, Lagunju IA, Bakare RA, Odekanmi AA, Adegbola RA. Invasive pneumococcal disease in children aged < 5 years admitted to 3 urban hospitals in Ibadan, Nigeria. Clin Infect Dis 2009;48:S190–6. doi:10.1086/596500 PMID:19191615 [ Links ]

    21. Adegbola RA, Secka O, Lahai G, Lloyd-Evans N, Njie A, Usen S et al. Elimination of Haemophilus influenzae type b (Hib) disease from the Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study. Lancet 2005;366:144–50. doi:10.1016/S0140-6736(05)66788-8 PMID:16005337 [ Links ]

    22. von Gottberg A, de Gouveia L, Madhi SA, du Plessis M, Quan V, Soma K et al. Impact of conjugate Haemophilus influenzae type b (Hib) vaccine introduction in South Africa. Bull World Health Organ 2006;84:811–8. doi:10.2471/BLT.06.030361 PMID:17128361 [ Links ]

    23. Gessner BD, Adegbola RA. The impact of vaccines on pneumonia: key lessons from Haemophilus influenzae type b conjugate vaccines. Vaccine 2008;26(Suppl 2):B3–8. doi:10.1016/j.vaccine.2008.04.013 PMID:18793604 [ Links ]

    24. Johnson HL, Deloria-Knoll M, Levine OS, Stoszek SK, Freimanis Hance L, Reithinger R et al. Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project. PLoS Med 2010;7:e1000348. doi:10.1371/journal.pmed.1000348 PMID:20957191 [ Links ]

    25. Hicks LA, Harrison LH, Flannery B, Hadler JL, Schaffner W, Craig AS et al. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis 2007;196:1346–54. doi:10.1086/521626 PMID:17922399 [ Links ]

    26. Morais L, Carvalho Mda G, Roca A, Flannery B, Mandomando I, Soriano-Gabarro M et al. Sequential multiplex PCR for identifying pneumococcal capsular serotypes from South-Saharan African clinical isolates. J Med Microbiol 2007;56:1181–4. doi:10.1099/jmm.0.47346-0 PMID:17761480 [ Links ]

    27. Dias CA, Teixeira LM, Carvalho Mda G, Beall B. Sequential multiplex PCR for determining capsular serotypes of pneumococci from Brazilian children. J Med Microbiol 2007;56:1185–8. doi:10.1099/jmm.0.47347-0 PMID:17761481 [ Links ]

    28. Njanpop Lafourcade BM, Sanou O, van der Linden M, Levina N, Karanfil M, Yaro S et al. Serotyping pneumococcal meningitis cases in the African meningitis belt by use of multiplex PCR with cerebrospinal fluid. J Clin Microbiol 2010;48:612–4. doi:10.1128/JCM.01402-09 PMID:20007384 [ Links ]

    29. Vestrheim DF, Lovoll O, Aaberge IS, Caugant DA, Hoiby EA, Bakke H et al. Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway. Vaccine 2008;26:3277–81. doi:10.1016/j.vaccine.2008.03.087 PMID:18456376 [ Links ]

    30. Amos B, Kisakye A, Makewa D, Mudhune S, Mwamtemi H, Nansera D et al. Behind the data: establishing the Network for Surveillance of Pneumococcal Disease in the East African Region. Clin Infect Dis 2009;48(Suppl 2):S162–71. doi:10.1086/596496 PMID:19191612 [ Links ]